{"gene":"TNFAIP3","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":2015,"finding":"Truncated A20 proteins from loss-of-function TNFAIP3 mutations act through haploinsufficiency (not dominant-negative effect) and fail to remove Lys63-linked ubiquitin from TRAF6, NEMO, and RIP1 after TNF stimulation, resulting in increased IκBα degradation and nuclear translocation of NF-κB p65.","method":"Overexpression experiments in patient-derived cells, immunoblotting for IκBα degradation, NF-κB p65 nuclear translocation assays, ubiquitin chain analysis of TRAF6/NEMO/RIP1","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (overexpression, patient-derived cells, ubiquitin chain analysis, nuclear translocation) in a single rigorous study with clear mechanistic conclusions","pmids":["26642243"],"is_preprint":false},{"year":2017,"finding":"TNFAIP3 directly interacts with and deubiquitinates ASK1 in hepatocytes, suppressing ASK1 activation; hepatocyte-specific ablation of Tnfaip3 exacerbates NASH phenotypes in an ASK1-dependent manner.","method":"Co-immunoprecipitation/protein interaction screen, hepatocyte-specific knockout mice, in vivo deubiquitination assay, ASK1-dependent rescue experiments","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct interaction identified by pulldown/Co-IP, genetic epistasis via conditional KO, ASK1-dependence confirmed by rescue, replicated in mouse and nonhuman primate models","pmids":["29227477"],"is_preprint":false},{"year":2010,"finding":"A20 deubiquitinates K63-polyubiquitin chains via its N-terminal OTU deubiquitinase domain and promotes K48-polyubiquitination (targeting substrates for proteasomal degradation) via its C-terminal zinc-finger ubiquitin-binding domain, which recruits E3 ligases such as Itch and RNF11.","method":"Review integrating in vitro deubiquitinase assays, domain mutagenesis, and protein interaction studies from multiple primary publications","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mechanistic model supported by prior in vitro assays and domain mutagenesis, but this paper is a review synthesizing others; confidence limited by review format","pmids":["20599425"],"is_preprint":false},{"year":2011,"finding":"TNFAIP3 deubiquitinates polyubiquitinated occludin in intestinal epithelial cells, maintaining tight junction integrity; TNFAIP3-/- mice show increased intestinal permeability while villin-TNFAIP3 transgenic mice are protected from LPS-induced barrier disruption.","method":"Knockout and transgenic mouse models, in vivo permeability assays, immunohistochemistry, in vitro deubiquitination assay on occludin","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct in vitro deubiquitination of occludin, corroborated by KO and transgenic mouse permeability data; single lab but multiple orthogonal methods","pmids":["22031828"],"is_preprint":false},{"year":2015,"finding":"TNFAIP3 binds to the mTOR complex and restricts mTOR activity by preventing enhanced ubiquitination of the mTOR complex; Tnfaip3-deficient CD4 T cells show enhanced mTOR activity and defective autophagy (reduced LC3 puncta, increased mitochondrial content, elevated ROS), leading to impaired survival rescued by mTOR inhibitor Torin1 in an Atg5-dependent manner.","method":"Tnfaip3-deficient mouse T cells, Co-IP of TNFAIP3 with mTOR complex, LC3 puncta assays, mitochondrial content measurement, ROS assay, Torin1 rescue experiment, Atg5 double-KO epistasis","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP binding, KO cellular phenotypes, pharmacological and genetic epistasis all in one study; single lab but multiple orthogonal methods","pmids":["26043155"],"is_preprint":false},{"year":2019,"finding":"TNFAIP3 alleles encoding A20 proteins with substitutions at non-catalytic OTU domain residues (T108A;I207L from Denisovans; I325N from ENU-mutagenized mice; C243Y from rare human variant) diminish IκB kinase-dependent phosphorylation and activation of A20, tuning immunity; partial phosphorylation-deficient variants increase immunity without spontaneous inflammation, while near-complete loss (C243Y, ~95% phosphorylation loss) causes spontaneous inflammatory disease.","method":"Genomic analysis of Denisovan/modern human/mouse TNFAIP3 alleles, IKK phosphorylation assays, LPS tolerance assays, poxvirus challenge in I325N mice, inflammatory disease phenotyping in C243Y mice and humans","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — phosphorylation mechanism defined by biochemical assays, validated across multiple species and alleles with functional in vivo phenotypes","pmids":["31534238"],"is_preprint":false},{"year":2017,"finding":"A20/TNFAIP3 binds and inhibits the E3 ubiquitin ligase RNF168 in a manner independent of its own enzymatic activity, disrupting RNF168-H2A interaction and inhibiting accumulation of RNF168 and 53BP1 at DNA damage sites; A20 deletion increases error-prone NHEJ and decreases error-free homologous recombination.","method":"Co-IP of A20 with RNF168, enzymatic activity-dead A20 mutants, 53BP1/RNF168 foci assays by immunofluorescence, NHEJ vs. HR reporter assays","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, enzymatic-dead mutants, and functional DNA repair assays; single lab with multiple orthogonal methods","pmids":["29233925"],"is_preprint":false},{"year":2018,"finding":"TNFAIP3 (A20) forms a complex with DEPTOR via its zinc-finger domains and together they promote early-onset autophagy after LPS stimulation to prevent NLRP3 inflammasome formation; in ankylosing spondylitis monocytes, deficiency of both TNFAIP3 and DEPTOR facilitates inflammasome activation.","method":"GST pull-down, yeast two-hybrid, confocal microscopy, Co-IP, transmission electron microscopy, RFP-GFP-LC3 autophagy reporter, LC3 immunoblot","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — TNFAIP3-DEPTOR interaction confirmed by three independent binding methods (GST pulldown, yeast two-hybrid, Co-IP); single lab","pmids":["29940800"],"is_preprint":false},{"year":2013,"finding":"Tnfaip3 transcription in LPS-stimulated macrophages is co-regulated by NF-κB and p38-dependent C/EBPβ; chromatin immunoprecipitation demonstrated C/EBPβ binding to the Tnfaip3 promoter, and C/EBPβ-ablated macrophages showed reduced Tnfaip3 expression.","method":"Chromatin immunoprecipitation (ChIP), microarray, p38 inhibitor treatment, IKK-depleted macrophages, C/EBPβ knockout macrophages","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP combined with genetic ablation of C/EBPβ and pharmacological inhibition of p38; single lab, two orthogonal methods","pmids":["24023826"],"is_preprint":false},{"year":2016,"finding":"A20 is required for NKT cell sublineage specification; it controls differentiation and survival of NKT1 and NKT2 (but not NKT17) sublineages through negative regulation of TCR signaling. Compound deficiency of MALT1 (a downstream TCR signaling component) restored defective NKT development in A20-deficient mice.","method":"T-cell-specific A20 conditional knockout mice, flow cytometry of NKT subsets, cytokine production assays after TCR ligation in vitro, MALT1/A20 double-knockout epistasis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with clear cellular phenotype, genetic epistasis with MALT1; single lab with multiple orthogonal methods","pmids":["27551157"],"is_preprint":false},{"year":2016,"finding":"Glucocorticoid receptor (GR) and NF-κB cooperatively regulate A20 (TNFAIP3) expression in human airway smooth muscle through direct binding to an intronic enhancer; A20, together with TNIP1, is required for maximal cytokine repression by glucocorticoids.","method":"Chromatin immunoprecipitation (ChIP), reporter gene assay for intronic enhancer, siRNA knockdown of A20, overexpression of A20 and TNIP1 in human airway smooth muscle cells","journal":"American journal of physiology. Lung cellular and molecular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay define enhancer binding; siRNA knockdown and overexpression confirm functional requirement; single lab, multiple orthogonal methods","pmids":["27371733"],"is_preprint":false},{"year":2017,"finding":"STAT3 activation by TNFR1 signaling induces Tnfaip3/A20 expression, which in turn limits TNF-induced inflammatory chemokine (Ccl2, Cxcl1, Cxcl10) production; STAT3 knockout MEFs fail to upregulate A20 upon TNF stimulation and show greater chemokine induction; enforced A20 expression in STAT3KO cells suppresses chemokine production.","method":"STAT3 knockout mouse embryo fibroblasts, RNA sequencing, pharmacological Jak2 inhibition, multiplex cytokine assays, immunoblotting, A20 overexpression rescue","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO fibroblasts with transcriptome analysis, pharmacological validation, and rescue overexpression; single lab, multiple methods","pmids":["35841281"],"is_preprint":false},{"year":2010,"finding":"The A125V coding polymorphism in the DUB domain of TNFAIP3 alters the deubiquitinating activity of the protein, as shown by functional DUB activity assays; this variant confers protection from SLE but risk for inflammatory bowel disease.","method":"In vitro DUB activity assay of A125V variant vs. wild-type, computer modeling of OTU domain structure, case-control association","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct DUB activity assay performed but single lab, limited methodological detail in abstract","pmids":["20483768"],"is_preprint":false},{"year":2022,"finding":"METTL14-mediated m6A modification of TNFAIP3 mRNA regulates its stability and translational efficiency; reduced METTL14/m6A in RA PBMCs decreases TNFAIP3 expression, promoting NF-κB-mediated inflammation.","method":"MeRIP sequencing, RNA immunoprecipitation, METTL14 knockdown in PBMCs and CAIA mouse model, mRNA stability assays","journal":"Arthritis & rheumatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MeRIP-seq identifies m6A sites on TNFAIP3 mRNA, functional impact confirmed by KD experiments in cells and in vivo; single lab, multiple orthogonal methods","pmids":["37327357"],"is_preprint":false},{"year":2018,"finding":"Autoimmunity-associated TNFAIP3 expression in primary immune cells is dependent on a topologically associating subdomain (sub-TAD) containing four enhancers; deletion of this sub-TAD or a specific SLE-associated enhancer (TT>A) results in enhanced inflammatory responses, autoantibody production, and inflammatory arthritis in humanized BAC transgenic mice.","method":"BAC transgenics, genome editing (sub-TAD and enhancer deletion), in vivo phenotyping for autoimmunity and inflammation, allele-specific reporter assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome editing with defined enhancer deletions, validated in primary immune cells and in vivo with multiple phenotypic readouts; rigorous mechanistic study","pmids":["29440643"],"is_preprint":false},{"year":2019,"finding":"TNFAIP3 is required for ubiquitination-dependent degradation of the EMT transcription factors Snail and ZEB1; depletion of TNFAIP3 reduces ubiquitin-mediated turnover of these factors, promoting EMT and increasing migration/invasion of gastric cancer cells.","method":"siRNA knockdown of TNFAIP3, overexpression, ubiquitination assay for Snail and ZEB1, migration/invasion assays","journal":"Pathology, research and practice","confidence":"Low","confidence_rationale":"Tier 3 / Weak — ubiquitination assay described but limited methodological detail; single lab, single paper","pmids":["31153693"],"is_preprint":false},{"year":2017,"finding":"A20/TNFAIP3 acts as a master regulator downstream of TNFR2 signaling in CD4+ T cells: TNF binding to TNFR2 maintains TNFAIP3/A20 expression, which suppresses p38 MAPK and PKC kinase activity, thereby preventing IL-17A production; anti-TNF treatment inhibits TNFAIP3/A20, derepressing these kinases and promoting IL-17A expression.","method":"siRNA knockdown of TNFAIP3, kinase activity assays (p38, PKC), flow cytometry, TNFR2-specific antibody experiments in isolated human CD4+ T cells, ex vivo patient samples","journal":"The Journal of allergy and clinical immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with kinase activity assays and TNFR2-specific reagents; single lab, multiple orthogonal methods","pmids":["29248493"],"is_preprint":false},{"year":2022,"finding":"YTHDF2 binds to m6A sites in the 3'UTR of TNFAIP3 mRNA and decreases its stability, leading to reduced TNFAIP3 expression and consequent activation of NF-κB signaling and TMZ resistance in glioblastoma.","method":"RNA immunoprecipitation, dual-luciferase reporter, FISH with immunostaining, mRNA stability assay, YTHDF2 knockdown/overexpression","journal":"Clinical & translational immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — m6A binding confirmed by RIP and reporter assay; mRNA stability shown; single lab, multiple orthogonal methods","pmids":["35582627"],"is_preprint":false},{"year":2016,"finding":"A novel C243Y missense mutation in the OTU domain of A20/TNFAIP3 impairs suppression of Nod2-mediated NF-κB activation; cells transfected with mutant C243Y A20 showed significantly less suppression of inflammatory cytokine secretion compared to wild-type A20.","method":"Whole-exome sequencing, transfection of wild-type vs. C243Y mutant A20 in cell lines, NF-κB luciferase reporter assay, cytokine measurement from patient-derived mononuclear cells","journal":"RMD open","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional NF-κB reporter and cytokine assays comparing WT vs. mutant A20; corroborated by PMID:31534238 which independently characterized C243Y","pmids":["27175295"],"is_preprint":false},{"year":2022,"finding":"In HA20 patients with a novel frameshift mutation (p.His577Alafs*95), A20 haploinsufficiency leads to increased p65 NF-κB phosphorylation and proinflammatory cytokine production; additionally, A20 modulates the IFNγ/STAT1 pathway, as patient monocytes show elevated basal STAT1 and enhanced phospho-STAT1 upon IFNγ stimulation, with elevated circulating CXCL9 and CXCL10.","method":"Next-generation sequencing, ex vivo LPS stimulation of patient PBMCs, NF-κB phosphorylation immunoblot, cytokine ELISA, STAT1 immunoblot, phospho-STAT1 flow cytometry, CXCL9/CXCL10 serum measurement","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient-derived cells with multiple pathway readouts; single lab, multiple orthogonal assays","pmids":["35154120"],"is_preprint":false},{"year":2022,"finding":"Tnfaip3 downregulation mediates a late phase of microglia proliferation after nerve injury in mouse spinal cord; restoring Tnfaip3 to baseline terminates this proliferative phase, and the late phase suppresses the early Myc-mediated phase.","method":"Single-cell RNA sequencing, flow cytometry, immunohistochemistry, sciatic nerve injury mouse model; Tnfaip3 expression manipulation","journal":"Cell discovery","confidence":"Low","confidence_rationale":"Tier 3 / Weak — correlative scRNAseq with some functional validation; mechanistic detail about how Tnfaip3 loss drives proliferation is limited in the abstract","pmids":["35411038"],"is_preprint":false},{"year":2023,"finding":"HIF1A directly suppresses the TNFAIP3 promoter under cadmium exposure; alpha-ketoglutarate (AKG) promotes HIF1A hydroxylation and degradation, preventing HIF1A-mediated TNFAIP3 repression and thereby maintaining NF-κB suppression in hepatocytes.","method":"AAV-mediated hepatocyte-specific TNFAIP3 overexpression, HIF1A pcDNA transfection rescue, in vivo mouse and cell experiments with cadmium and AKG treatment","journal":"The Science of the total environment","confidence":"Low","confidence_rationale":"Tier 3 / Weak — mechanism inferred from overexpression and rescue experiments; HIF1A-TNFAIP3 promoter interaction stated mechanistically but direct promoter binding assay not described in abstract","pmids":["36996991"],"is_preprint":false}],"current_model":"TNFAIP3 encodes A20, a dual-function ubiquitin-editing enzyme with an N-terminal OTU deubiquitinase domain that removes K63-linked ubiquitin chains from NF-κB pathway components (TRAF6, NEMO, RIP1) and a C-terminal zinc-finger domain that recruits E3 ligases (Itch, RNF11) to promote K48-linked ubiquitination of substrates for proteasomal degradation; IKK-dependent phosphorylation at non-catalytic OTU residues activates A20, and hypomorphic TNFAIP3 alleles that diminish this phosphorylation tune the balance between immunity and inflammatory disease. Beyond NF-κB, A20 directly deubiquitinates and inactivates ASK1 in hepatocytes, deubiquitinates occludin to maintain tight junction integrity, binds the mTOR complex to restrict mTOR activity and promote autophagy in T cells, interacts with DEPTOR to prevent NLRP3 inflammasome assembly, and inhibits the E3 ligase RNF168 (independently of its catalytic activity) to regulate DNA damage responses."},"narrative":{"mechanistic_narrative":"TNFAIP3 encodes A20, a ubiquitin-editing enzyme that restrains NF-κB-driven inflammation by removing Lys63-linked ubiquitin chains from the signaling components TRAF6, NEMO, and RIP1 through its N-terminal OTU deubiquitinase domain, while its C-terminal zinc-finger domain promotes Lys48-linked ubiquitination of substrates for proteasomal degradation by recruiting E3 ligases such as Itch and RNF11 [PMID:26642243, PMID:20599425]. Loss-of-function truncating mutations act through haploinsufficiency, failing to clear K63 chains and producing excess IκBα degradation and nuclear translocation of NF-κB p65, the molecular basis of A20 haploinsufficiency (HA20) inflammatory disease [PMID:26642243, PMID:35411038]. A20 activity is tuned by IKK-dependent phosphorylation at non-catalytic OTU residues: partial phosphorylation-deficient alleles heighten immunity without overt inflammation, whereas near-complete loss (C243Y) causes spontaneous inflammatory disease, and the C243Y substitution impairs suppression of Nod2-driven NF-κB activation [PMID:31534238, PMID:27175295]. Beyond canonical NF-κB control, A20 carries out tissue-specific regulatory functions: it directly deubiquitinates and inactivates ASK1 in hepatocytes to limit NASH [PMID:29227477], deubiquitinates occludin to preserve intestinal tight-junction integrity [PMID:22031828], binds and restrains the mTOR complex to license autophagy in CD4 T cells [PMID:26043155], partners with DEPTOR via its zinc fingers to drive early autophagy and prevent NLRP3 inflammasome assembly [PMID:29940800], and inhibits the E3 ligase RNF168 independently of its catalytic activity to shape the DNA-damage response toward homologous recombination [PMID:29233925]. A20 also restrains T-cell receptor signaling to specify NKT cell sublineages [PMID:27551157] and is itself an inducible feedback node controlled transcriptionally by NF-κB/C/EBPβ, STAT3, and glucocorticoid receptor, and post-transcriptionally by METTL14-deposited m6A read by YTHDF2 [PMID:24023826, PMID:35841281, PMID:37327357, PMID:35582627].","teleology":[{"year":2010,"claim":"Established the dual ubiquitin-editing architecture of A20, distinguishing its K63-deubiquitinase OTU domain from its K48-promoting zinc-finger module, framing how a single protein both removes and adds ubiquitin marks.","evidence":"Review integrating in vitro deubiquitinase assays, domain mutagenesis, and E3-ligase (Itch, RNF11) interaction studies","pmids":["20599425"],"confidence":"Medium","gaps":["Synthesized from prior work rather than new primary data","Does not establish in vivo substrate specificity quantitatively"]},{"year":2010,"claim":"Showed that a natural DUB-domain polymorphism (A125V) alters enzymatic activity and partitions disease risk, linking catalytic tuning to opposing autoimmune phenotypes.","evidence":"In vitro DUB activity assay of A125V vs. wild-type, OTU structural modeling, case-control association","pmids":["20483768"],"confidence":"Medium","gaps":["Limited methodological detail","Mechanism connecting altered DUB activity to divergent SLE vs. IBD outcomes not resolved"]},{"year":2011,"claim":"Extended A20 function beyond immune signaling by demonstrating it deubiquitinates occludin to maintain epithelial barrier integrity.","evidence":"Knockout and villin-transgenic mice, in vivo permeability assays, in vitro deubiquitination of occludin","pmids":["22031828"],"confidence":"High","gaps":["Ubiquitin linkage type on occludin not specified","Single-lab finding"]},{"year":2013,"claim":"Defined how Tnfaip3 itself is induced, showing co-regulation by NF-κB and p38-dependent C/EBPβ as a transcriptional feedback loop.","evidence":"ChIP for C/EBPβ promoter binding, p38 inhibition, IKK depletion, C/EBPβ knockout macrophages","pmids":["24023826"],"confidence":"Medium","gaps":["Relative contribution of NF-κB vs. C/EBPβ not quantified","Does not address post-transcriptional control"]},{"year":2015,"claim":"Demonstrated that human loss-of-function mutations cause disease through haploinsufficiency and failure to strip K63 chains from TRAF6/NEMO/RIP1, anchoring the molecular pathology of HA20.","evidence":"Patient-derived cells, overexpression, ubiquitin chain analysis, IκBα and p65 nuclear translocation assays","pmids":["26642243"],"confidence":"High","gaps":["Does not address whether some alleles act dominant-negatively in other contexts","Tissue-specific consequences not dissected"]},{"year":2015,"claim":"Connected A20 to metabolic and autophagy control by showing it binds the mTOR complex to restrain mTOR activity and sustain T-cell autophagy and survival.","evidence":"Tnfaip3-deficient T cells, Co-IP with mTOR complex, LC3/mitochondrial/ROS assays, Torin1 and Atg5 epistasis","pmids":["26043155"],"confidence":"High","gaps":["Which mTOR complex component is the ubiquitination target unclear","Role of catalytic vs. scaffold function not separated"]},{"year":2016,"claim":"Showed A20 restrains TCR signaling to specify NKT1/NKT2 sublineages, broadening its role into lymphocyte developmental programming.","evidence":"T-cell-specific conditional knockout, NKT subset flow cytometry, MALT1 double-knockout epistasis","pmids":["27551157"],"confidence":"High","gaps":["Direct substrates in the TCR pathway not identified","Why NKT17 is spared unexplained"]},{"year":2016,"claim":"Identified glucocorticoid receptor/NF-κB cooperative induction of A20 via an intronic enhancer, mechanistically linking A20 to glucocorticoid anti-inflammatory action.","evidence":"ChIP, intronic enhancer reporter assay, A20 siRNA, A20/TNIP1 overexpression in airway smooth muscle","pmids":["27371733"],"confidence":"Medium","gaps":["Generalizability beyond airway smooth muscle untested","TNIP1 mechanistic contribution undefined"]},{"year":2016,"claim":"Characterized the C243Y OTU-domain mutation as impairing suppression of Nod2-mediated NF-κB, providing a defined disease allele.","evidence":"Whole-exome sequencing, WT vs. C243Y transfection, NF-κB luciferase, cytokine measurement","pmids":["27175295"],"confidence":"Medium","gaps":["Whether C243Y affects catalysis or another property not resolved here"]},{"year":2017,"claim":"Revealed a hepatocyte-specific role: A20 directly deubiquitinates and inactivates ASK1 to protect against NASH.","evidence":"Co-IP/interaction screen, hepatocyte-specific knockout mice, in vivo deubiquitination, ASK1-dependent rescue","pmids":["29227477"],"confidence":"High","gaps":["Ubiquitin linkage on ASK1 not specified","Crosstalk with A20's NF-κB role in liver not delineated"]},{"year":2017,"claim":"Placed A20 downstream of TNFR2 in CD4 T cells, showing it suppresses p38/PKC to block IL-17A, explaining anti-TNF-induced derepression.","evidence":"siRNA knockdown, p38/PKC kinase assays, TNFR2-specific antibodies, patient samples","pmids":["29248493"],"confidence":"Medium","gaps":["Direct ubiquitin substrates linking A20 to kinase suppression not identified"]},{"year":2017,"claim":"Identified a non-catalytic A20 function: inhibition of E3 ligase RNF168 to limit 53BP1 recruitment and bias DNA repair toward homologous recombination.","evidence":"Reciprocal Co-IP, activity-dead A20 mutants, 53BP1/RNF168 foci, NHEJ vs. HR reporters","pmids":["29233925"],"confidence":"Medium","gaps":["Structural basis of RNF168-H2A disruption unresolved","Physiological relevance in vivo untested"]},{"year":2017,"claim":"Showed STAT3 induction of A20 acts as a brake on TNF-induced chemokine output, adding another inducible feedback input.","evidence":"STAT3-KO MEFs, RNA-seq, Jak2 inhibition, A20 overexpression rescue","pmids":["35841281"],"confidence":"Medium","gaps":["Direct STAT3 binding to the Tnfaip3 locus not shown"]},{"year":2018,"claim":"Demonstrated A20 partners with DEPTOR through its zinc fingers to drive early autophagy and prevent NLRP3 inflammasome assembly.","evidence":"GST pull-down, yeast two-hybrid, Co-IP, electron microscopy, RFP-GFP-LC3 reporter in ankylosing spondylitis monocytes","pmids":["29940800"],"confidence":"Medium","gaps":["Whether A20 ubiquitin-editing acts on DEPTOR or NLRP3 components unclear"]},{"year":2018,"claim":"Defined cis-regulatory architecture controlling A20 expression, showing a sub-TAD with autoimmunity-associated enhancers governs inflammatory tone in vivo.","evidence":"Humanized BAC transgenics, genome editing of sub-TAD/enhancer, autoimmunity phenotyping, allele-specific reporters","pmids":["29440643"],"confidence":"High","gaps":["Trans-acting factors at each enhancer not fully mapped"]},{"year":2019,"claim":"Established that IKK-dependent phosphorylation at non-catalytic OTU residues activates A20 and that allelic variation in this phosphorylation tunes the immunity–inflammation balance across species.","evidence":"Genomic analysis of Denisovan/human/mouse alleles, IKK phosphorylation assays, LPS tolerance, poxvirus challenge, disease phenotyping","pmids":["31534238"],"confidence":"High","gaps":["How phosphorylation mechanistically enhances catalysis or substrate engagement not fully resolved"]},{"year":2019,"claim":"Linked A20 to tumor biology by showing it drives ubiquitin-mediated degradation of EMT factors Snail and ZEB1, restraining gastric cancer migration.","evidence":"siRNA knockdown, overexpression, Snail/ZEB1 ubiquitination and migration/invasion assays","pmids":["31153693"],"confidence":"Low","gaps":["Limited methodological detail; not independently confirmed","Direct vs. indirect ubiquitination not distinguished"]},{"year":2022,"claim":"Demonstrated post-transcriptional control of TNFAIP3 by m6A: METTL14 deposition stabilizes its mRNA while YTHDF2 reading destabilizes it, tuning NF-κB output in disease.","evidence":"MeRIP-seq, RIP, METTL14/YTHDF2 knockdown, mRNA stability and reporter assays in RA and glioblastoma models","pmids":["37327357","35582627"],"confidence":"Medium","gaps":["Which m6A site dominates regulation unclear","Interplay between METTL14 writing and YTHDF2 reading not co-analyzed"]},{"year":2022,"claim":"Extended HA20 pathology to interferon signaling, showing A20 deficiency elevates STAT1 and CXCL9/CXCL10 in addition to NF-κB hyperactivation.","evidence":"NGS, patient PBMC LPS stimulation, NF-κB and STAT1 phospho-readouts, CXCL9/10 serum measurement","pmids":["35154120"],"confidence":"Medium","gaps":["Whether A20 acts directly on the IFNγ/STAT1 axis or indirectly via NF-κB unresolved"]},{"year":2022,"claim":"Implicated Tnfaip3 downregulation in timing a late phase of injury-induced microglial proliferation in the CNS.","evidence":"Single-cell RNA-seq, flow cytometry, immunohistochemistry, Tnfaip3 manipulation in sciatic nerve injury model","pmids":["35411038"],"confidence":"Low","gaps":["Largely correlative; mechanism of how Tnfaip3 loss drives proliferation undefined"]},{"year":2023,"claim":"Proposed HIF1A-mediated transcriptional repression of TNFAIP3 under cadmium stress, reversible by alpha-ketoglutarate-driven HIF1A degradation.","evidence":"Hepatocyte-specific TNFAIP3 overexpression AAV, HIF1A rescue transfection, cadmium/AKG treatment in mice and cells","pmids":["36996991"],"confidence":"Low","gaps":["Direct HIF1A binding to the TNFAIP3 promoter not demonstrated","Mechanism inferred from overexpression/rescue only"]},{"year":null,"claim":"How A20's catalytic (OTU deubiquitination, zinc-finger-directed K48 ubiquitination) and non-catalytic scaffold activities are selectively deployed across its many substrates and tissue contexts remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified structural model coupling phosphorylation, substrate choice, and catalytic vs. scaffold output","Linkage specificity on several substrates (occludin, ASK1, mTOR complex) undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,2,3]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,2,12]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,6,7]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[7]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,4]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,5,9,16]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,16]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[4,7]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[6]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[13,17]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[8,10,11,14]}],"complexes":[],"partners":["TRAF6","RIPK1","IKBKG","ASK1","MTOR","DEPTOR","RNF168","OCLN"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P21580","full_name":"Tumor necrosis factor alpha-induced protein 3","aliases":["OTU domain-containing protein 7C","Putative DNA-binding protein A20","Zinc finger protein A20"],"length_aa":790,"mass_kda":89.6,"function":"Ubiquitin-editing enzyme that contains both ubiquitin ligase and deubiquitinase activities. Involved in immune and inflammatory responses signaled by cytokines, such as TNF and IL-1 beta, or pathogens via Toll-like receptors (TLRs) through terminating NF-kappa-B activity. Essential component of a ubiquitin-editing protein complex, comprising also RNF11, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. In cooperation with TAX1BP1 promotes disassembly of E2-E3 ubiquitin protein ligase complexes in IL-1R and TNFR-1 pathways; affected are at least E3 ligases TRAF6, TRAF2 and BIRC2, and E2 ubiquitin-conjugating enzymes UBE2N and UBE2D3. In cooperation with TAX1BP1 promotes ubiquitination of UBE2N and proteasomal degradation of UBE2N and UBE2D3. Upon TNF stimulation, deubiquitinates 'Lys-63'-polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. Deubiquitinates TRAF6 probably acting on 'Lys-63'-linked polyubiquitin. Upon T-cell receptor (TCR)-mediated T-cell activation, deubiquitinates 'Lys-63'-polyubiquitin chains on MALT1 thereby mediating disassociation of the CBM (CARD11:BCL10:MALT1) and IKK complexes and preventing sustained IKK activation. Deubiquitinates NEMO/IKBKG; the function is facilitated by TNIP1 and leads to inhibition of NF-kappa-B activation. Upon stimulation by bacterial peptidoglycans, probably deubiquitinates RIPK2. Can also inhibit I-kappa-B-kinase (IKK) through a non-catalytic mechanism which involves polyubiquitin; polyubiquitin promotes association with IKBKG and prevents IKK MAP3K7-mediated phosphorylation. Targets TRAF2 for lysosomal degradation. In vitro able to deubiquitinate 'Lys-11'-, 'Lys-48'- and 'Lys-63' polyubiquitin chains. Inhibitor of programmed cell death. Has a role in the function of the lymphoid system. Required for LPS-induced production of pro-inflammatory cytokines and IFN beta in LPS-tolerized macrophages","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P21580/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TNFAIP3","classification":"Not Classified","n_dependent_lines":24,"n_total_lines":1208,"dependency_fraction":0.019867549668874173},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TNFAIP3","total_profiled":1310},"omim":[{"mim_id":"618287","title":"AUTOINFLAMMATORY DISEASE, FAMILIAL, BEHCET-LIKE 3; AIFBL3","url":"https://www.omim.org/entry/618287"},{"mim_id":"616744","title":"AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE 1; AIFBL1","url":"https://www.omim.org/entry/616744"},{"mim_id":"616137","title":"MICRO RNA 873; MIR873","url":"https://www.omim.org/entry/616137"},{"mim_id":"612378","title":"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 13; SLEB13","url":"https://www.omim.org/entry/612378"},{"mim_id":"611749","title":"ZINC FINGER RANBP2-TYPE DOMAIN-CONTAINING PROTEIN 1; ZRANB1","url":"https://www.omim.org/entry/611749"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Centrosome","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":393.5},{"tissue":"urinary bladder","ntpm":146.3}],"url":"https://www.proteinatlas.org/search/TNFAIP3"},"hgnc":{"alias_symbol":["A20","OTUD7C"],"prev_symbol":[]},"alphafold":{"accession":"P21580","domains":[{"cath_id":"3.90.70.80","chopping":"11-346","consensus_level":"high","plddt":92.32,"start":11,"end":346}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P21580","model_url":"https://alphafold.ebi.ac.uk/files/AF-P21580-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P21580-F1-predicted_aligned_error_v6.png","plddt_mean":73.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TNFAIP3","jax_strain_url":"https://www.jax.org/strain/search?query=TNFAIP3"},"sequence":{"accession":"P21580","fasta_url":"https://rest.uniprot.org/uniprotkb/P21580.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P21580/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P21580"}},"corpus_meta":[{"pmid":"26642243","id":"PMC_26642243","title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease.","date":"2015","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26642243","citation_count":501,"is_preprint":false},{"pmid":"19643665","id":"PMC_19643665","title":"The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.","date":"2009","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19643665","citation_count":391,"is_preprint":false},{"pmid":"19380639","id":"PMC_19380639","title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.","date":"2009","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19380639","citation_count":373,"is_preprint":false},{"pmid":"19608751","id":"PMC_19608751","title":"TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19608751","citation_count":250,"is_preprint":false},{"pmid":"20599425","id":"PMC_20599425","title":"Expression, biological activities and mechanisms of action of A20 (TNFAIP3).","date":"2010","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20599425","citation_count":188,"is_preprint":false},{"pmid":"29227477","id":"PMC_29227477","title":"The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis.","date":"2017","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29227477","citation_count":166,"is_preprint":false},{"pmid":"21088135","id":"PMC_21088135","title":"B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21088135","citation_count":161,"is_preprint":false},{"pmid":"19240061","id":"PMC_19240061","title":"Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.","date":"2009","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/19240061","citation_count":158,"is_preprint":false},{"pmid":"22113471","id":"PMC_22113471","title":"TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis.","date":"2011","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/22113471","citation_count":144,"is_preprint":false},{"pmid":"29654213","id":"PMC_29654213","title":"Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB.","date":"2018","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/29654213","citation_count":142,"is_preprint":false},{"pmid":"21763284","id":"PMC_21763284","title":"miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21763284","citation_count":125,"is_preprint":false},{"pmid":"26043155","id":"PMC_26043155","title":"TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.","date":"2015","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/26043155","citation_count":118,"is_preprint":false},{"pmid":"21326317","id":"PMC_21326317","title":"Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases.","date":"2011","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/21326317","citation_count":102,"is_preprint":false},{"pmid":"24159176","id":"PMC_24159176","title":"Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24159176","citation_count":101,"is_preprint":false},{"pmid":"32268115","id":"PMC_32268115","title":"TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation.","date":"2020","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32268115","citation_count":92,"is_preprint":false},{"pmid":"21787353","id":"PMC_21787353","title":"Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease.","date":"2011","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/21787353","citation_count":86,"is_preprint":false},{"pmid":"20483768","id":"PMC_20483768","title":"African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20483768","citation_count":83,"is_preprint":false},{"pmid":"17297453","id":"PMC_17297453","title":"A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17297453","citation_count":82,"is_preprint":false},{"pmid":"27919278","id":"PMC_27919278","title":"MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.","date":"2016","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/27919278","citation_count":77,"is_preprint":false},{"pmid":"24901050","id":"PMC_24901050","title":"miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/24901050","citation_count":72,"is_preprint":false},{"pmid":"27979905","id":"PMC_27979905","title":"A long noncoding RNA, lincRNA-Tnfaip3, acts as a coregulator of NF-κB to modulate inflammatory gene transcription in mouse macrophages.","date":"2016","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/27979905","citation_count":72,"is_preprint":false},{"pmid":"19387456","id":"PMC_19387456","title":"Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations.","date":"2009","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/19387456","citation_count":71,"is_preprint":false},{"pmid":"17886247","id":"PMC_17886247","title":"TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma.","date":"2008","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17886247","citation_count":71,"is_preprint":false},{"pmid":"21905002","id":"PMC_21905002","title":"Gene-gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus.","date":"2012","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/21905002","citation_count":70,"is_preprint":false},{"pmid":"27175295","id":"PMC_27175295","title":"Novel heterozygous C243Y A20/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Behçet's disease.","date":"2016","source":"RMD open","url":"https://pubmed.ncbi.nlm.nih.gov/27175295","citation_count":70,"is_preprint":false},{"pmid":"33549125","id":"PMC_33549125","title":"Mesenchymal stem cell-originated exosomal lncRNA HAND2-AS1 impairs rheumatoid arthritis fibroblast-like synoviocyte activation through miR-143-3p/TNFAIP3/NF-κB pathway.","date":"2021","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/33549125","citation_count":66,"is_preprint":false},{"pmid":"20822710","id":"PMC_20822710","title":"Functional evaluation of TNFAIP3 (A20) in rheumatoid arthritis.","date":"2010","source":"Clinical and experimental rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/20822710","citation_count":64,"is_preprint":false},{"pmid":"22031828","id":"PMC_22031828","title":"TNFAIP3 maintains intestinal barrier function and supports epithelial cell tight junctions.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22031828","citation_count":61,"is_preprint":false},{"pmid":"28751561","id":"PMC_28751561","title":"Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.","date":"2017","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/28751561","citation_count":59,"is_preprint":false},{"pmid":"30543305","id":"PMC_30543305","title":"Regulators of A20 (TNFAIP3): new drug-able targets in inflammation.","date":"2018","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30543305","citation_count":58,"is_preprint":false},{"pmid":"31534238","id":"PMC_31534238","title":"Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunity.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31534238","citation_count":57,"is_preprint":false},{"pmid":"30213788","id":"PMC_30213788","title":"Nedd4-Binding Protein 1 and TNFAIP3-Interacting Protein 1 Control MHC-1 Display in Neuroblastoma.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30213788","citation_count":54,"is_preprint":false},{"pmid":"30118730","id":"PMC_30118730","title":"Keratinocyte Expression of A20/TNFAIP3 Controls Skin Inflammation Associated with Atopic Dermatitis and Psoriasis.","date":"2018","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/30118730","citation_count":52,"is_preprint":false},{"pmid":"21604024","id":"PMC_21604024","title":"A failure of TNFAIP3 negative regulation maintains sustained NF-κB activation in Sjögren's syndrome.","date":"2011","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21604024","citation_count":49,"is_preprint":false},{"pmid":"31534975","id":"PMC_31534975","title":"TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients.","date":"2019","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/31534975","citation_count":48,"is_preprint":false},{"pmid":"29940800","id":"PMC_29940800","title":"TNFAIP3-DEPTOR complex regulates inflammasome secretion through autophagy in ankylosing spondylitis monocytes.","date":"2018","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/29940800","citation_count":45,"is_preprint":false},{"pmid":"32144282","id":"PMC_32144282","title":"Prioritizing disease and trait causal variants at the TNFAIP3 locus using functional and genomic features.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32144282","citation_count":44,"is_preprint":false},{"pmid":"29327472","id":"PMC_29327472","title":"Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-κB/SMAD pathway in patients with immune thrombocytopenia.","date":"2018","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/29327472","citation_count":43,"is_preprint":false},{"pmid":"22402800","id":"PMC_22402800","title":"Associations between TNFAIP3 gene polymorphisms and rheumatoid arthritis: a meta-analysis.","date":"2012","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/22402800","citation_count":42,"is_preprint":false},{"pmid":"34133792","id":"PMC_34133792","title":"TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury.","date":"2021","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/34133792","citation_count":39,"is_preprint":false},{"pmid":"29233925","id":"PMC_29233925","title":"A20/TNFAIP3 Regulates the DNA Damage Response and Mediates Tumor Cell Resistance to DNA-Damaging Therapy.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29233925","citation_count":36,"is_preprint":false},{"pmid":"29248493","id":"PMC_29248493","title":"TNF-α-induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade-driven IL-17A expression.","date":"2017","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29248493","citation_count":36,"is_preprint":false},{"pmid":"23635951","id":"PMC_23635951","title":"Association studies of TNFSF4, TNFAIP3 and FAM167A-BLK polymorphisms with primary Sjogren's syndrome in Han Chinese.","date":"2013","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23635951","citation_count":36,"is_preprint":false},{"pmid":"37327357","id":"PMC_37327357","title":"METTL14-Mediated m6A Modification of TNFAIP3 Involved in Inflammation in Patients With Active Rheumatoid Arthritis.","date":"2023","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/37327357","citation_count":35,"is_preprint":false},{"pmid":"33173336","id":"PMC_33173336","title":"Circ-ATP5H Induces Hepatitis B Virus Replication and Expression by Regulating miR-138-5p/TNFAIP3 Axis.","date":"2020","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33173336","citation_count":34,"is_preprint":false},{"pmid":"27551157","id":"PMC_27551157","title":"NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20.","date":"2016","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27551157","citation_count":33,"is_preprint":false},{"pmid":"26199174","id":"PMC_26199174","title":"Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia.","date":"2015","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26199174","citation_count":33,"is_preprint":false},{"pmid":"24023826","id":"PMC_24023826","title":"Transcription of Tnfaip3 is regulated by NF-κB and p38 via C/EBPβ in activated macrophages.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24023826","citation_count":33,"is_preprint":false},{"pmid":"30301877","id":"PMC_30301877","title":"Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma.","date":"2018","source":"Blood cancer journal","url":"https://pubmed.ncbi.nlm.nih.gov/30301877","citation_count":32,"is_preprint":false},{"pmid":"25521225","id":"PMC_25521225","title":"Meta-analysis of the TNFAIP3 region in psoriasis reveals a risk haplotype that is distinct from other autoimmune diseases.","date":"2014","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/25521225","citation_count":32,"is_preprint":false},{"pmid":"29440643","id":"PMC_29440643","title":"Dissection and function of autoimmunity-associated TNFAIP3 (A20) gene enhancers in humanized mouse models.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29440643","citation_count":31,"is_preprint":false},{"pmid":"28158872","id":"PMC_28158872","title":"TNFAIP3 downregulation mediated by histone modification contributes to T-cell dysfunction in systemic lupus erythematosus.","date":"2017","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28158872","citation_count":31,"is_preprint":false},{"pmid":"25302371","id":"PMC_25302371","title":"Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.","date":"2014","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/25302371","citation_count":29,"is_preprint":false},{"pmid":"32514655","id":"PMC_32514655","title":"Haploinsufficiency of A20 Due to Novel Mutations in TNFAIP3.","date":"2020","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32514655","citation_count":27,"is_preprint":false},{"pmid":"31153693","id":"PMC_31153693","title":"The potential role of TNFAIP3 in malignant transformation of gastric carcinoma.","date":"2019","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/31153693","citation_count":26,"is_preprint":false},{"pmid":"27371733","id":"PMC_27371733","title":"Glucocorticoid and TNF signaling converge at A20 (TNFAIP3) to repress airway smooth muscle cytokine expression.","date":"2016","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27371733","citation_count":26,"is_preprint":false},{"pmid":"25337792","id":"PMC_25337792","title":"Genetic association study of TNFAIP3, IFIH1, IRF5 polymorphisms with polymyositis/dermatomyositis in Chinese Han population.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25337792","citation_count":26,"is_preprint":false},{"pmid":"21406721","id":"PMC_21406721","title":"A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21406721","citation_count":26,"is_preprint":false},{"pmid":"23418597","id":"PMC_23418597","title":"A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23418597","citation_count":25,"is_preprint":false},{"pmid":"35411038","id":"PMC_35411038","title":"Distinct phases of adult microglia proliferation: a Myc-mediated early phase and a Tnfaip3-mediated late phase.","date":"2022","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/35411038","citation_count":25,"is_preprint":false},{"pmid":"30041578","id":"PMC_30041578","title":"Association of ITGAM, TNFSF4, TNFAIP3 and STAT4 gene polymorphisms with risk of systemic lupus erythematosus in a North Indian population.","date":"2018","source":"Lupus","url":"https://pubmed.ncbi.nlm.nih.gov/30041578","citation_count":25,"is_preprint":false},{"pmid":"31452243","id":"PMC_31452243","title":"miR-605-5p promotes invasion and proliferation by targeting TNFAIP3 in non-small-cell lung cancer.","date":"2019","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31452243","citation_count":24,"is_preprint":false},{"pmid":"36325013","id":"PMC_36325013","title":"Novel loss-of-function mutations in TNFAIP3 gene in patients with lupus nephritis.","date":"2022","source":"Clinical kidney journal","url":"https://pubmed.ncbi.nlm.nih.gov/36325013","citation_count":24,"is_preprint":false},{"pmid":"35841281","id":"PMC_35841281","title":"STAT3 regulates inflammatory cytokine production downstream of TNFR1 by inducing expression of TNFAIP3/A20.","date":"2022","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35841281","citation_count":24,"is_preprint":false},{"pmid":"22595989","id":"PMC_22595989","title":"Expression of TNFAIP3 in intestinal epithelial cells protects from DSS- but not TNBS-induced colitis.","date":"2012","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22595989","citation_count":24,"is_preprint":false},{"pmid":"30810840","id":"PMC_30810840","title":"Novel Heterogeneous Mutation of TNFAIP3 in a Chinese Patient with Behçet-Like Phenotype and Persistent EBV Viremia.","date":"2019","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30810840","citation_count":24,"is_preprint":false},{"pmid":"26474180","id":"PMC_26474180","title":"Identification of an Association of TNFAIP3 Polymorphisms With Matrix Metalloproteinase Expression in Fibroblasts in an Integrative Study of Systemic Sclerosis-Associated Genetic and Environmental Factors.","date":"2016","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/26474180","citation_count":23,"is_preprint":false},{"pmid":"36996991","id":"PMC_36996991","title":"Alpha-ketoglutarate alleviates cadmium-induced inflammation by inhibiting the HIF1A-TNFAIP3 pathway in hepatocytes.","date":"2023","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/36996991","citation_count":23,"is_preprint":false},{"pmid":"24798189","id":"PMC_24798189","title":"Polymorphisms of the TNFAIP3 region and Graves' disease.","date":"2014","source":"Autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/24798189","citation_count":23,"is_preprint":false},{"pmid":"30662920","id":"PMC_30662920","title":"TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients.","date":"2018","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/30662920","citation_count":23,"is_preprint":false},{"pmid":"21208380","id":"PMC_21208380","title":"The association between BANK1 and TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta-analysis.","date":"2011","source":"International journal of immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/21208380","citation_count":22,"is_preprint":false},{"pmid":"35093867","id":"PMC_35093867","title":"The A20/TNFAIP3-CDC20-CASP1 Axis Promotes Inflammation-mediated Metastatic Disease in Triple-negative Breast Cancer.","date":"2022","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/35093867","citation_count":22,"is_preprint":false},{"pmid":"32755457","id":"PMC_32755457","title":"DNGR1-Cre-mediated Deletion of Tnfaip3/A20 in Conventional Dendritic Cells Induces Pulmonary Hypertension in Mice.","date":"2020","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/32755457","citation_count":22,"is_preprint":false},{"pmid":"32280718","id":"PMC_32280718","title":"Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation.","date":"2020","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/32280718","citation_count":22,"is_preprint":false},{"pmid":"33226960","id":"PMC_33226960","title":"TNFAIP3 ameliorates the degeneration of inflammatory human nucleus pulposus cells by inhibiting mTOR signaling and promoting autophagy.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/33226960","citation_count":21,"is_preprint":false},{"pmid":"33981308","id":"PMC_33981308","title":"Ebosin Ameliorates Psoriasis-Like Inflammation of Mice via miR-155 Targeting tnfaip3 on IL-17 Pathway.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33981308","citation_count":20,"is_preprint":false},{"pmid":"25684197","id":"PMC_25684197","title":"Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case-control cohort.","date":"2015","source":"International journal of immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/25684197","citation_count":19,"is_preprint":false},{"pmid":"39125844","id":"PMC_39125844","title":"Genetic Mutations Associated With TNFAIP3 (A20) Haploinsufficiency and Their Impact on Inflammatory Diseases.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39125844","citation_count":18,"is_preprint":false},{"pmid":"35154120","id":"PMC_35154120","title":"Identification of a Novel Mutation in TNFAIP3 in a Family With Poly-Autoimmunity.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35154120","citation_count":18,"is_preprint":false},{"pmid":"33224133","id":"PMC_33224133","title":"TNFAIP3 Plays a Role in Aging of the Hematopoietic System.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33224133","citation_count":18,"is_preprint":false},{"pmid":"32285140","id":"PMC_32285140","title":"The impact of DNA demethylation on the upregulation of the NRN1 and TNFAIP3 genes associated with advanced gastric cancer.","date":"2020","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/32285140","citation_count":18,"is_preprint":false},{"pmid":"24489017","id":"PMC_24489017","title":"TNFAIP3 gene polymorphisms associated with differential susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Korean population.","date":"2014","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24489017","citation_count":18,"is_preprint":false},{"pmid":"22924496","id":"PMC_22924496","title":"Associations between TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta-analysis.","date":"2012","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/22924496","citation_count":17,"is_preprint":false},{"pmid":"31120955","id":"PMC_31120955","title":"Low TNFAIP3 expression in psoriatic skin promotes disease susceptibility and severity.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31120955","citation_count":17,"is_preprint":false},{"pmid":"29486471","id":"PMC_29486471","title":"TNFAIP3 mRNA Level Is Associated with Psychological Anxiety in Major Depressive Disorder.","date":"2018","source":"Neuroimmunomodulation","url":"https://pubmed.ncbi.nlm.nih.gov/29486471","citation_count":17,"is_preprint":false},{"pmid":"31384100","id":"PMC_31384100","title":"Autosomal dominant Hashimoto's thyroiditis with a mutation in TNFAIP3.","date":"2019","source":"Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31384100","citation_count":17,"is_preprint":false},{"pmid":"22397314","id":"PMC_22397314","title":"Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma.","date":"2012","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/22397314","citation_count":17,"is_preprint":false},{"pmid":"25234043","id":"PMC_25234043","title":"Intestinal epithelial expression of TNFAIP3 results in microbial invasion of the inner mucus layer and induces colitis in IL-10-deficient mice.","date":"2014","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25234043","citation_count":17,"is_preprint":false},{"pmid":"20533286","id":"PMC_20533286","title":"Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in CLL.","date":"2010","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20533286","citation_count":17,"is_preprint":false},{"pmid":"37097268","id":"PMC_37097268","title":"The impact of the cytoplasmic ubiquitin ligase TNFAIP3 gene variation on transcription factor NF-κB activation in acute kidney injury.","date":"2023","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/37097268","citation_count":16,"is_preprint":false},{"pmid":"34808442","id":"PMC_34808442","title":"A novel missense mutation in TNFAIP3 causes haploinsufficiency of A20.","date":"2021","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34808442","citation_count":15,"is_preprint":false},{"pmid":"28253718","id":"PMC_28253718","title":"TNFAIP3 inhibits migration and invasion in nasopharyngeal carcinoma by suppressing epithelial mesenchymal transition.","date":"2017","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/28253718","citation_count":15,"is_preprint":false},{"pmid":"26738398","id":"PMC_26738398","title":"TNFAIP3 and TNIP1 polymorphisms confer psoriasis risk in South Indian Tamils.","date":"2015","source":"British journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/26738398","citation_count":15,"is_preprint":false},{"pmid":"36587050","id":"PMC_36587050","title":"MEG3 alleviates ankylosing spondylitis by suppressing osteogenic differentiation of mesenchymal stem cells through regulating microRNA-125a-5p-mediated TNFAIP3.","date":"2022","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/36587050","citation_count":15,"is_preprint":false},{"pmid":"31151831","id":"PMC_31151831","title":"DNGR1-mediated deletion of A20/Tnfaip3 in dendritic cells alters T and B-cell homeostasis and promotes autoimmune liver pathology.","date":"2019","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/31151831","citation_count":15,"is_preprint":false},{"pmid":"32329078","id":"PMC_32329078","title":"Tnfaip3 expression in pulmonary conventional type 1 Langerin-expressing dendritic cells regulates T helper 2-mediated airway inflammation in mice.","date":"2020","source":"Allergy","url":"https://pubmed.ncbi.nlm.nih.gov/32329078","citation_count":15,"is_preprint":false},{"pmid":"37148522","id":"PMC_37148522","title":"Aberrant Histone Modification of TNFAIP3, TLR4, TNIP2, miR-146a, and miR-155 in Major Depressive Disorder.","date":"2023","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/37148522","citation_count":14,"is_preprint":false},{"pmid":"35582627","id":"PMC_35582627","title":"YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the Akt and NF-κB signalling pathways via inhibiting EPHB3 and TNFAIP3.","date":"2022","source":"Clinical & translational immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35582627","citation_count":14,"is_preprint":false},{"pmid":"32709905","id":"PMC_32709905","title":"Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32709905","citation_count":14,"is_preprint":false},{"pmid":"36064566","id":"PMC_36064566","title":"TNFAIP3 mutation causing haploinsufficiency of A20 with a hemophagocytic lymphohistiocytosis phenotype: a report of two cases.","date":"2022","source":"Pediatric rheumatology online journal","url":"https://pubmed.ncbi.nlm.nih.gov/36064566","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":57218,"output_tokens":5936,"usd":0.130347,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14524,"output_tokens":6020,"usd":0.11156,"stage2_stop_reason":"end_turn"},"total_usd":0.241907,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2015,\n      \"finding\": \"Truncated A20 proteins from loss-of-function TNFAIP3 mutations act through haploinsufficiency (not dominant-negative effect) and fail to remove Lys63-linked ubiquitin from TRAF6, NEMO, and RIP1 after TNF stimulation, resulting in increased IκBα degradation and nuclear translocation of NF-κB p65.\",\n      \"method\": \"Overexpression experiments in patient-derived cells, immunoblotting for IκBα degradation, NF-κB p65 nuclear translocation assays, ubiquitin chain analysis of TRAF6/NEMO/RIP1\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (overexpression, patient-derived cells, ubiquitin chain analysis, nuclear translocation) in a single rigorous study with clear mechanistic conclusions\",\n      \"pmids\": [\"26642243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TNFAIP3 directly interacts with and deubiquitinates ASK1 in hepatocytes, suppressing ASK1 activation; hepatocyte-specific ablation of Tnfaip3 exacerbates NASH phenotypes in an ASK1-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation/protein interaction screen, hepatocyte-specific knockout mice, in vivo deubiquitination assay, ASK1-dependent rescue experiments\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct interaction identified by pulldown/Co-IP, genetic epistasis via conditional KO, ASK1-dependence confirmed by rescue, replicated in mouse and nonhuman primate models\",\n      \"pmids\": [\"29227477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A20 deubiquitinates K63-polyubiquitin chains via its N-terminal OTU deubiquitinase domain and promotes K48-polyubiquitination (targeting substrates for proteasomal degradation) via its C-terminal zinc-finger ubiquitin-binding domain, which recruits E3 ligases such as Itch and RNF11.\",\n      \"method\": \"Review integrating in vitro deubiquitinase assays, domain mutagenesis, and protein interaction studies from multiple primary publications\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mechanistic model supported by prior in vitro assays and domain mutagenesis, but this paper is a review synthesizing others; confidence limited by review format\",\n      \"pmids\": [\"20599425\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TNFAIP3 deubiquitinates polyubiquitinated occludin in intestinal epithelial cells, maintaining tight junction integrity; TNFAIP3-/- mice show increased intestinal permeability while villin-TNFAIP3 transgenic mice are protected from LPS-induced barrier disruption.\",\n      \"method\": \"Knockout and transgenic mouse models, in vivo permeability assays, immunohistochemistry, in vitro deubiquitination assay on occludin\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct in vitro deubiquitination of occludin, corroborated by KO and transgenic mouse permeability data; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"22031828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TNFAIP3 binds to the mTOR complex and restricts mTOR activity by preventing enhanced ubiquitination of the mTOR complex; Tnfaip3-deficient CD4 T cells show enhanced mTOR activity and defective autophagy (reduced LC3 puncta, increased mitochondrial content, elevated ROS), leading to impaired survival rescued by mTOR inhibitor Torin1 in an Atg5-dependent manner.\",\n      \"method\": \"Tnfaip3-deficient mouse T cells, Co-IP of TNFAIP3 with mTOR complex, LC3 puncta assays, mitochondrial content measurement, ROS assay, Torin1 rescue experiment, Atg5 double-KO epistasis\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP binding, KO cellular phenotypes, pharmacological and genetic epistasis all in one study; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"26043155\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TNFAIP3 alleles encoding A20 proteins with substitutions at non-catalytic OTU domain residues (T108A;I207L from Denisovans; I325N from ENU-mutagenized mice; C243Y from rare human variant) diminish IκB kinase-dependent phosphorylation and activation of A20, tuning immunity; partial phosphorylation-deficient variants increase immunity without spontaneous inflammation, while near-complete loss (C243Y, ~95% phosphorylation loss) causes spontaneous inflammatory disease.\",\n      \"method\": \"Genomic analysis of Denisovan/modern human/mouse TNFAIP3 alleles, IKK phosphorylation assays, LPS tolerance assays, poxvirus challenge in I325N mice, inflammatory disease phenotyping in C243Y mice and humans\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — phosphorylation mechanism defined by biochemical assays, validated across multiple species and alleles with functional in vivo phenotypes\",\n      \"pmids\": [\"31534238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A20/TNFAIP3 binds and inhibits the E3 ubiquitin ligase RNF168 in a manner independent of its own enzymatic activity, disrupting RNF168-H2A interaction and inhibiting accumulation of RNF168 and 53BP1 at DNA damage sites; A20 deletion increases error-prone NHEJ and decreases error-free homologous recombination.\",\n      \"method\": \"Co-IP of A20 with RNF168, enzymatic activity-dead A20 mutants, 53BP1/RNF168 foci assays by immunofluorescence, NHEJ vs. HR reporter assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, enzymatic-dead mutants, and functional DNA repair assays; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"29233925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TNFAIP3 (A20) forms a complex with DEPTOR via its zinc-finger domains and together they promote early-onset autophagy after LPS stimulation to prevent NLRP3 inflammasome formation; in ankylosing spondylitis monocytes, deficiency of both TNFAIP3 and DEPTOR facilitates inflammasome activation.\",\n      \"method\": \"GST pull-down, yeast two-hybrid, confocal microscopy, Co-IP, transmission electron microscopy, RFP-GFP-LC3 autophagy reporter, LC3 immunoblot\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — TNFAIP3-DEPTOR interaction confirmed by three independent binding methods (GST pulldown, yeast two-hybrid, Co-IP); single lab\",\n      \"pmids\": [\"29940800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Tnfaip3 transcription in LPS-stimulated macrophages is co-regulated by NF-κB and p38-dependent C/EBPβ; chromatin immunoprecipitation demonstrated C/EBPβ binding to the Tnfaip3 promoter, and C/EBPβ-ablated macrophages showed reduced Tnfaip3 expression.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), microarray, p38 inhibitor treatment, IKK-depleted macrophages, C/EBPβ knockout macrophages\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP combined with genetic ablation of C/EBPβ and pharmacological inhibition of p38; single lab, two orthogonal methods\",\n      \"pmids\": [\"24023826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A20 is required for NKT cell sublineage specification; it controls differentiation and survival of NKT1 and NKT2 (but not NKT17) sublineages through negative regulation of TCR signaling. Compound deficiency of MALT1 (a downstream TCR signaling component) restored defective NKT development in A20-deficient mice.\",\n      \"method\": \"T-cell-specific A20 conditional knockout mice, flow cytometry of NKT subsets, cytokine production assays after TCR ligation in vitro, MALT1/A20 double-knockout epistasis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with clear cellular phenotype, genetic epistasis with MALT1; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"27551157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Glucocorticoid receptor (GR) and NF-κB cooperatively regulate A20 (TNFAIP3) expression in human airway smooth muscle through direct binding to an intronic enhancer; A20, together with TNIP1, is required for maximal cytokine repression by glucocorticoids.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), reporter gene assay for intronic enhancer, siRNA knockdown of A20, overexpression of A20 and TNIP1 in human airway smooth muscle cells\",\n      \"journal\": \"American journal of physiology. Lung cellular and molecular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay define enhancer binding; siRNA knockdown and overexpression confirm functional requirement; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"27371733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"STAT3 activation by TNFR1 signaling induces Tnfaip3/A20 expression, which in turn limits TNF-induced inflammatory chemokine (Ccl2, Cxcl1, Cxcl10) production; STAT3 knockout MEFs fail to upregulate A20 upon TNF stimulation and show greater chemokine induction; enforced A20 expression in STAT3KO cells suppresses chemokine production.\",\n      \"method\": \"STAT3 knockout mouse embryo fibroblasts, RNA sequencing, pharmacological Jak2 inhibition, multiplex cytokine assays, immunoblotting, A20 overexpression rescue\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO fibroblasts with transcriptome analysis, pharmacological validation, and rescue overexpression; single lab, multiple methods\",\n      \"pmids\": [\"35841281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The A125V coding polymorphism in the DUB domain of TNFAIP3 alters the deubiquitinating activity of the protein, as shown by functional DUB activity assays; this variant confers protection from SLE but risk for inflammatory bowel disease.\",\n      \"method\": \"In vitro DUB activity assay of A125V variant vs. wild-type, computer modeling of OTU domain structure, case-control association\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct DUB activity assay performed but single lab, limited methodological detail in abstract\",\n      \"pmids\": [\"20483768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"METTL14-mediated m6A modification of TNFAIP3 mRNA regulates its stability and translational efficiency; reduced METTL14/m6A in RA PBMCs decreases TNFAIP3 expression, promoting NF-κB-mediated inflammation.\",\n      \"method\": \"MeRIP sequencing, RNA immunoprecipitation, METTL14 knockdown in PBMCs and CAIA mouse model, mRNA stability assays\",\n      \"journal\": \"Arthritis & rheumatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MeRIP-seq identifies m6A sites on TNFAIP3 mRNA, functional impact confirmed by KD experiments in cells and in vivo; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"37327357\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Autoimmunity-associated TNFAIP3 expression in primary immune cells is dependent on a topologically associating subdomain (sub-TAD) containing four enhancers; deletion of this sub-TAD or a specific SLE-associated enhancer (TT>A) results in enhanced inflammatory responses, autoantibody production, and inflammatory arthritis in humanized BAC transgenic mice.\",\n      \"method\": \"BAC transgenics, genome editing (sub-TAD and enhancer deletion), in vivo phenotyping for autoimmunity and inflammation, allele-specific reporter assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome editing with defined enhancer deletions, validated in primary immune cells and in vivo with multiple phenotypic readouts; rigorous mechanistic study\",\n      \"pmids\": [\"29440643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TNFAIP3 is required for ubiquitination-dependent degradation of the EMT transcription factors Snail and ZEB1; depletion of TNFAIP3 reduces ubiquitin-mediated turnover of these factors, promoting EMT and increasing migration/invasion of gastric cancer cells.\",\n      \"method\": \"siRNA knockdown of TNFAIP3, overexpression, ubiquitination assay for Snail and ZEB1, migration/invasion assays\",\n      \"journal\": \"Pathology, research and practice\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — ubiquitination assay described but limited methodological detail; single lab, single paper\",\n      \"pmids\": [\"31153693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A20/TNFAIP3 acts as a master regulator downstream of TNFR2 signaling in CD4+ T cells: TNF binding to TNFR2 maintains TNFAIP3/A20 expression, which suppresses p38 MAPK and PKC kinase activity, thereby preventing IL-17A production; anti-TNF treatment inhibits TNFAIP3/A20, derepressing these kinases and promoting IL-17A expression.\",\n      \"method\": \"siRNA knockdown of TNFAIP3, kinase activity assays (p38, PKC), flow cytometry, TNFR2-specific antibody experiments in isolated human CD4+ T cells, ex vivo patient samples\",\n      \"journal\": \"The Journal of allergy and clinical immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with kinase activity assays and TNFR2-specific reagents; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"29248493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"YTHDF2 binds to m6A sites in the 3'UTR of TNFAIP3 mRNA and decreases its stability, leading to reduced TNFAIP3 expression and consequent activation of NF-κB signaling and TMZ resistance in glioblastoma.\",\n      \"method\": \"RNA immunoprecipitation, dual-luciferase reporter, FISH with immunostaining, mRNA stability assay, YTHDF2 knockdown/overexpression\",\n      \"journal\": \"Clinical & translational immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — m6A binding confirmed by RIP and reporter assay; mRNA stability shown; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"35582627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A novel C243Y missense mutation in the OTU domain of A20/TNFAIP3 impairs suppression of Nod2-mediated NF-κB activation; cells transfected with mutant C243Y A20 showed significantly less suppression of inflammatory cytokine secretion compared to wild-type A20.\",\n      \"method\": \"Whole-exome sequencing, transfection of wild-type vs. C243Y mutant A20 in cell lines, NF-κB luciferase reporter assay, cytokine measurement from patient-derived mononuclear cells\",\n      \"journal\": \"RMD open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional NF-κB reporter and cytokine assays comparing WT vs. mutant A20; corroborated by PMID:31534238 which independently characterized C243Y\",\n      \"pmids\": [\"27175295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In HA20 patients with a novel frameshift mutation (p.His577Alafs*95), A20 haploinsufficiency leads to increased p65 NF-κB phosphorylation and proinflammatory cytokine production; additionally, A20 modulates the IFNγ/STAT1 pathway, as patient monocytes show elevated basal STAT1 and enhanced phospho-STAT1 upon IFNγ stimulation, with elevated circulating CXCL9 and CXCL10.\",\n      \"method\": \"Next-generation sequencing, ex vivo LPS stimulation of patient PBMCs, NF-κB phosphorylation immunoblot, cytokine ELISA, STAT1 immunoblot, phospho-STAT1 flow cytometry, CXCL9/CXCL10 serum measurement\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient-derived cells with multiple pathway readouts; single lab, multiple orthogonal assays\",\n      \"pmids\": [\"35154120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Tnfaip3 downregulation mediates a late phase of microglia proliferation after nerve injury in mouse spinal cord; restoring Tnfaip3 to baseline terminates this proliferative phase, and the late phase suppresses the early Myc-mediated phase.\",\n      \"method\": \"Single-cell RNA sequencing, flow cytometry, immunohistochemistry, sciatic nerve injury mouse model; Tnfaip3 expression manipulation\",\n      \"journal\": \"Cell discovery\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — correlative scRNAseq with some functional validation; mechanistic detail about how Tnfaip3 loss drives proliferation is limited in the abstract\",\n      \"pmids\": [\"35411038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HIF1A directly suppresses the TNFAIP3 promoter under cadmium exposure; alpha-ketoglutarate (AKG) promotes HIF1A hydroxylation and degradation, preventing HIF1A-mediated TNFAIP3 repression and thereby maintaining NF-κB suppression in hepatocytes.\",\n      \"method\": \"AAV-mediated hepatocyte-specific TNFAIP3 overexpression, HIF1A pcDNA transfection rescue, in vivo mouse and cell experiments with cadmium and AKG treatment\",\n      \"journal\": \"The Science of the total environment\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — mechanism inferred from overexpression and rescue experiments; HIF1A-TNFAIP3 promoter interaction stated mechanistically but direct promoter binding assay not described in abstract\",\n      \"pmids\": [\"36996991\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TNFAIP3 encodes A20, a dual-function ubiquitin-editing enzyme with an N-terminal OTU deubiquitinase domain that removes K63-linked ubiquitin chains from NF-κB pathway components (TRAF6, NEMO, RIP1) and a C-terminal zinc-finger domain that recruits E3 ligases (Itch, RNF11) to promote K48-linked ubiquitination of substrates for proteasomal degradation; IKK-dependent phosphorylation at non-catalytic OTU residues activates A20, and hypomorphic TNFAIP3 alleles that diminish this phosphorylation tune the balance between immunity and inflammatory disease. Beyond NF-κB, A20 directly deubiquitinates and inactivates ASK1 in hepatocytes, deubiquitinates occludin to maintain tight junction integrity, binds the mTOR complex to restrict mTOR activity and promote autophagy in T cells, interacts with DEPTOR to prevent NLRP3 inflammasome assembly, and inhibits the E3 ligase RNF168 (independently of its catalytic activity) to regulate DNA damage responses.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TNFAIP3 encodes A20, a ubiquitin-editing enzyme that restrains NF-κB-driven inflammation by removing Lys63-linked ubiquitin chains from the signaling components TRAF6, NEMO, and RIP1 through its N-terminal OTU deubiquitinase domain, while its C-terminal zinc-finger domain promotes Lys48-linked ubiquitination of substrates for proteasomal degradation by recruiting E3 ligases such as Itch and RNF11 [#0, #2]. Loss-of-function truncating mutations act through haploinsufficiency, failing to clear K63 chains and producing excess IκBα degradation and nuclear translocation of NF-κB p65, the molecular basis of A20 haploinsufficiency (HA20) inflammatory disease [#0, #20]. A20 activity is tuned by IKK-dependent phosphorylation at non-catalytic OTU residues: partial phosphorylation-deficient alleles heighten immunity without overt inflammation, whereas near-complete loss (C243Y) causes spontaneous inflammatory disease, and the C243Y substitution impairs suppression of Nod2-driven NF-κB activation [#5, #18]. Beyond canonical NF-κB control, A20 carries out tissue-specific regulatory functions: it directly deubiquitinates and inactivates ASK1 in hepatocytes to limit NASH [#1], deubiquitinates occludin to preserve intestinal tight-junction integrity [#3], binds and restrains the mTOR complex to license autophagy in CD4 T cells [#4], partners with DEPTOR via its zinc fingers to drive early autophagy and prevent NLRP3 inflammasome assembly [#7], and inhibits the E3 ligase RNF168 independently of its catalytic activity to shape the DNA-damage response toward homologous recombination [#6]. A20 also restrains T-cell receptor signaling to specify NKT cell sublineages [#9] and is itself an inducible feedback node controlled transcriptionally by NF-κB/C/EBPβ, STAT3, and glucocorticoid receptor, and post-transcriptionally by METTL14-deposited m6A read by YTHDF2 [#8, #11, #13, #17].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Established the dual ubiquitin-editing architecture of A20, distinguishing its K63-deubiquitinase OTU domain from its K48-promoting zinc-finger module, framing how a single protein both removes and adds ubiquitin marks.\",\n      \"evidence\": \"Review integrating in vitro deubiquitinase assays, domain mutagenesis, and E3-ligase (Itch, RNF11) interaction studies\",\n      \"pmids\": [\"20599425\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Synthesized from prior work rather than new primary data\", \"Does not establish in vivo substrate specificity quantitatively\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showed that a natural DUB-domain polymorphism (A125V) alters enzymatic activity and partitions disease risk, linking catalytic tuning to opposing autoimmune phenotypes.\",\n      \"evidence\": \"In vitro DUB activity assay of A125V vs. wild-type, OTU structural modeling, case-control association\",\n      \"pmids\": [\"20483768\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Limited methodological detail\", \"Mechanism connecting altered DUB activity to divergent SLE vs. IBD outcomes not resolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Extended A20 function beyond immune signaling by demonstrating it deubiquitinates occludin to maintain epithelial barrier integrity.\",\n      \"evidence\": \"Knockout and villin-transgenic mice, in vivo permeability assays, in vitro deubiquitination of occludin\",\n      \"pmids\": [\"22031828\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ubiquitin linkage type on occludin not specified\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined how Tnfaip3 itself is induced, showing co-regulation by NF-κB and p38-dependent C/EBPβ as a transcriptional feedback loop.\",\n      \"evidence\": \"ChIP for C/EBPβ promoter binding, p38 inhibition, IKK depletion, C/EBPβ knockout macrophages\",\n      \"pmids\": [\"24023826\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution of NF-κB vs. C/EBPβ not quantified\", \"Does not address post-transcriptional control\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated that human loss-of-function mutations cause disease through haploinsufficiency and failure to strip K63 chains from TRAF6/NEMO/RIP1, anchoring the molecular pathology of HA20.\",\n      \"evidence\": \"Patient-derived cells, overexpression, ubiquitin chain analysis, IκBα and p65 nuclear translocation assays\",\n      \"pmids\": [\"26642243\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address whether some alleles act dominant-negatively in other contexts\", \"Tissue-specific consequences not dissected\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Connected A20 to metabolic and autophagy control by showing it binds the mTOR complex to restrain mTOR activity and sustain T-cell autophagy and survival.\",\n      \"evidence\": \"Tnfaip3-deficient T cells, Co-IP with mTOR complex, LC3/mitochondrial/ROS assays, Torin1 and Atg5 epistasis\",\n      \"pmids\": [\"26043155\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which mTOR complex component is the ubiquitination target unclear\", \"Role of catalytic vs. scaffold function not separated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed A20 restrains TCR signaling to specify NKT1/NKT2 sublineages, broadening its role into lymphocyte developmental programming.\",\n      \"evidence\": \"T-cell-specific conditional knockout, NKT subset flow cytometry, MALT1 double-knockout epistasis\",\n      \"pmids\": [\"27551157\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct substrates in the TCR pathway not identified\", \"Why NKT17 is spared unexplained\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified glucocorticoid receptor/NF-κB cooperative induction of A20 via an intronic enhancer, mechanistically linking A20 to glucocorticoid anti-inflammatory action.\",\n      \"evidence\": \"ChIP, intronic enhancer reporter assay, A20 siRNA, A20/TNIP1 overexpression in airway smooth muscle\",\n      \"pmids\": [\"27371733\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generalizability beyond airway smooth muscle untested\", \"TNIP1 mechanistic contribution undefined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Characterized the C243Y OTU-domain mutation as impairing suppression of Nod2-mediated NF-κB, providing a defined disease allele.\",\n      \"evidence\": \"Whole-exome sequencing, WT vs. C243Y transfection, NF-κB luciferase, cytokine measurement\",\n      \"pmids\": [\"27175295\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether C243Y affects catalysis or another property not resolved here\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Revealed a hepatocyte-specific role: A20 directly deubiquitinates and inactivates ASK1 to protect against NASH.\",\n      \"evidence\": \"Co-IP/interaction screen, hepatocyte-specific knockout mice, in vivo deubiquitination, ASK1-dependent rescue\",\n      \"pmids\": [\"29227477\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ubiquitin linkage on ASK1 not specified\", \"Crosstalk with A20's NF-κB role in liver not delineated\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Placed A20 downstream of TNFR2 in CD4 T cells, showing it suppresses p38/PKC to block IL-17A, explaining anti-TNF-induced derepression.\",\n      \"evidence\": \"siRNA knockdown, p38/PKC kinase assays, TNFR2-specific antibodies, patient samples\",\n      \"pmids\": [\"29248493\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ubiquitin substrates linking A20 to kinase suppression not identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified a non-catalytic A20 function: inhibition of E3 ligase RNF168 to limit 53BP1 recruitment and bias DNA repair toward homologous recombination.\",\n      \"evidence\": \"Reciprocal Co-IP, activity-dead A20 mutants, 53BP1/RNF168 foci, NHEJ vs. HR reporters\",\n      \"pmids\": [\"29233925\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of RNF168-H2A disruption unresolved\", \"Physiological relevance in vivo untested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed STAT3 induction of A20 acts as a brake on TNF-induced chemokine output, adding another inducible feedback input.\",\n      \"evidence\": \"STAT3-KO MEFs, RNA-seq, Jak2 inhibition, A20 overexpression rescue\",\n      \"pmids\": [\"35841281\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct STAT3 binding to the Tnfaip3 locus not shown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated A20 partners with DEPTOR through its zinc fingers to drive early autophagy and prevent NLRP3 inflammasome assembly.\",\n      \"evidence\": \"GST pull-down, yeast two-hybrid, Co-IP, electron microscopy, RFP-GFP-LC3 reporter in ankylosing spondylitis monocytes\",\n      \"pmids\": [\"29940800\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether A20 ubiquitin-editing acts on DEPTOR or NLRP3 components unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined cis-regulatory architecture controlling A20 expression, showing a sub-TAD with autoimmunity-associated enhancers governs inflammatory tone in vivo.\",\n      \"evidence\": \"Humanized BAC transgenics, genome editing of sub-TAD/enhancer, autoimmunity phenotyping, allele-specific reporters\",\n      \"pmids\": [\"29440643\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trans-acting factors at each enhancer not fully mapped\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established that IKK-dependent phosphorylation at non-catalytic OTU residues activates A20 and that allelic variation in this phosphorylation tunes the immunity–inflammation balance across species.\",\n      \"evidence\": \"Genomic analysis of Denisovan/human/mouse alleles, IKK phosphorylation assays, LPS tolerance, poxvirus challenge, disease phenotyping\",\n      \"pmids\": [\"31534238\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How phosphorylation mechanistically enhances catalysis or substrate engagement not fully resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linked A20 to tumor biology by showing it drives ubiquitin-mediated degradation of EMT factors Snail and ZEB1, restraining gastric cancer migration.\",\n      \"evidence\": \"siRNA knockdown, overexpression, Snail/ZEB1 ubiquitination and migration/invasion assays\",\n      \"pmids\": [\"31153693\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Limited methodological detail; not independently confirmed\", \"Direct vs. indirect ubiquitination not distinguished\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated post-transcriptional control of TNFAIP3 by m6A: METTL14 deposition stabilizes its mRNA while YTHDF2 reading destabilizes it, tuning NF-κB output in disease.\",\n      \"evidence\": \"MeRIP-seq, RIP, METTL14/YTHDF2 knockdown, mRNA stability and reporter assays in RA and glioblastoma models\",\n      \"pmids\": [\"37327357\", \"35582627\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Which m6A site dominates regulation unclear\", \"Interplay between METTL14 writing and YTHDF2 reading not co-analyzed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extended HA20 pathology to interferon signaling, showing A20 deficiency elevates STAT1 and CXCL9/CXCL10 in addition to NF-κB hyperactivation.\",\n      \"evidence\": \"NGS, patient PBMC LPS stimulation, NF-κB and STAT1 phospho-readouts, CXCL9/10 serum measurement\",\n      \"pmids\": [\"35154120\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether A20 acts directly on the IFNγ/STAT1 axis or indirectly via NF-κB unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Implicated Tnfaip3 downregulation in timing a late phase of injury-induced microglial proliferation in the CNS.\",\n      \"evidence\": \"Single-cell RNA-seq, flow cytometry, immunohistochemistry, Tnfaip3 manipulation in sciatic nerve injury model\",\n      \"pmids\": [\"35411038\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Largely correlative; mechanism of how Tnfaip3 loss drives proliferation undefined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Proposed HIF1A-mediated transcriptional repression of TNFAIP3 under cadmium stress, reversible by alpha-ketoglutarate-driven HIF1A degradation.\",\n      \"evidence\": \"Hepatocyte-specific TNFAIP3 overexpression AAV, HIF1A rescue transfection, cadmium/AKG treatment in mice and cells\",\n      \"pmids\": [\"36996991\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Direct HIF1A binding to the TNFAIP3 promoter not demonstrated\", \"Mechanism inferred from overexpression/rescue only\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How A20's catalytic (OTU deubiquitination, zinc-finger-directed K48 ubiquitination) and non-catalytic scaffold activities are selectively deployed across its many substrates and tissue contexts remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified structural model coupling phosphorylation, substrate choice, and catalytic vs. scaffold output\", \"Linkage specificity on several substrates (occludin, ASK1, mTOR complex) undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 2, 3]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 2, 12]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 6, 7]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 5, 9, 16]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 16]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [4, 7]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [13, 17]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [8, 10, 11, 14]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"TRAF6\", \"RIPK1\", \"IKBKG\", \"ASK1\", \"MTOR\", \"DEPTOR\", \"RNF168\", \"OCLN\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}